Related references
Note: Only part of the references are listed.Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
Aleix Prat et al.
EBIOMEDICINE (2022)
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
Barbara Cardinali et al.
CANCERS (2022)
Circulating MicroRNAs as a New Class of Biomarkers of Physiological Reactions of the Organism to the Intake of Dietary Supplements and Drugs
Pavel V. Postnikov et al.
MicroRNA (Shariqah, United Arab Emirates) (2022)
Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer A Prospective, Multicenter Clinical Trial
Matthew G. Davey et al.
ANNALS OF SURGERY (2022)
miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
Zhuo Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
Satoko Takizawa et al.
CANCER BIOMARKERS (2022)
Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis
Thu H. N. Nguyen et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients
Oana Baldasici et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer
Valentina K. Todorova et al.
CURRENT ONCOLOGY (2022)
microRNAstrand selection: Unwinding the rules
Jeffrey C. Medley et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
Zhuo Zhang et al.
THORACIC CANCER (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
Circulating miRNA analysis for cancer diagnostics and therapy
Lukas Valihrach et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy
Zhang Shan et al.
FRONTIERS IN ONCOLOGY (2020)
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
Andrew McGuire et al.
CANCERS (2020)
Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients
Alaa M Ibrahim et al.
TUMOR BIOLOGY (2020)
Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab
Baoquan Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Marcelo A. Mori et al.
CELL METABOLISM (2019)
Prognostic role of microRNAs in breast cancer: A systematic review
Eleni Zografos et al.
Oncotarget (2019)
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
Alba Rodriguez-Martinez et al.
BREAST CANCER RESEARCH (2019)
Extracellular RNA profiles with human age
Douglas F. Dluzen et al.
AGING CELL (2018)
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Ines Stevic et al.
BMC MEDICINE (2018)
Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer
Marcia M. Marques et al.
CLINICS (2018)
Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients
Sebastian Niedzwiecki et al.
GINEKOLOGIA POLSKA (2018)
Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer
Wenjie Zhu et al.
CANCER MEDICINE (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer
Baoquan Liu et al.
HUMAN PATHOLOGY (2017)
Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer
Baoquan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer
Doireann P. Joyce et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients
Prasant Yadav et al.
TUMOR BIOLOGY (2016)
Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment
Manal Al-Khanbashi et al.
PLOS ONE (2016)
Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation
Elena Landoni et al.
BMC BIOINFORMATICS (2015)
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer
Lei Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Biomarker: Predictive or Prognostic?
Karla V. Ballman
JOURNAL OF CLINICAL ONCOLOGY (2015)
Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females
Guinian Wang et al.
ANNALS OF LABORATORY MEDICINE (2015)
Challenges in Using Circulating miRNAs as Cancer Biomarkers
Paola Tiberio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression
Pierre Freres et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer
C. Palmieri et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial
Volkmar Mueller et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer
Fu-long Zhao et al.
MOLECULAR BIOLOGY REPORTS (2014)
Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
Qian Li et al.
PLOS ONE (2014)
Smoking alters circulating plasma microvesicle pattern and microRNA signatures
Sigrun Badrnya et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy
Ugur Gezer et al.
ONCOLOGY LETTERS (2014)
Does regulation of skeletal muscle function involve circulating microRNAs?
Wataru Aoi et al.
FRONTIERS IN PHYSIOLOGY (2014)
Pre-analytical variables in miRNA analysis
Nils Becker et al.
CLINICAL BIOCHEMISTRY (2013)
miRNA profiling of cancer
Gianpiero Di Leva et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease
Hetty C. de Boer et al.
EUROPEAN HEART JOURNAL (2013)
Quantification of Circulating miRNAs in Plasma Effect of Preanalytical and Analytical Parameters on Their Isolation and Stability
Ioanna S. Sourvinou et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels
Heather H. Cheng et al.
PLOS ONE (2013)
Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men
Wataru Aoi et al.
FRONTIERS IN PHYSIOLOGY (2013)
Neoadjuvant treatment of breast cancer
A. M. Thompson et al.
ANNALS OF ONCOLOGY (2012)
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
Eun-Jung Jung et al.
CANCER (2012)
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Colin C. Pritchard et al.
CANCER PREVENTION RESEARCH (2012)
Lipid-based carriers of microRNAs and intercellular communication
Kasey C. Vickers et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies
Mireille Broeders et al.
JOURNAL OF MEDICAL SCREENING (2012)
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer
Xiwei Wu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Hongjiang Wang et al.
PLOS ONE (2012)
XenomiRs and miRNA homeostasis in health and disease Evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles
Kenneth W. Witwer
RNA BIOLOGY (2012)
Analytical challenges and technical limitations in assessing circulating MiRNAs
Anna Zampetaki et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Posttranscriptional Upregulation by MicroRNAs
Shobha Vasudevan
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
Jennifer S. McDonald et al.
CLINICAL CHEMISTRY (2011)
Circulating microRNAs: Association with disease and potential use as biomarkers
Glen Reid et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy
Ruihua Zhao et al.
ONKOLOGIE (2011)
Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
Radha Duttagupta et al.
PLOS ONE (2011)
Haemolysis during Sample Preparation Alters microRNA Content of Plasma
Michaela B. Kirschner et al.
PLOS ONE (2011)
Plasma miRNA as Biomarkers for Assessment of Total-Body Radiation Exposure Dosimetry
Wanchang Cui et al.
PLOS ONE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Strengths and Limitations of Laboratory Procedures for MicroRNA Detection
Jill Koshiol et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Export of microRNAs and microRNA-protective protein by mammalian cells
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
Helen M. Heneghan et al.
ONCOLOGIST (2010)
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Hua Zhao et al.
PLOS ONE (2010)
Functional delivery of viral miRNAs via exosomes
D. Michiel Pegtel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Carina Roth et al.
BREAST CANCER RESEARCH (2010)
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
Maria Angelica Cortez et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Technical variables in high-throughput miRNA expression profiling: Much work remains to be done
Peter T. Nelson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Share Paper
